Ukraine health ministry starts technical assessment of Valion Bio’s Entolimod dossier

• Ukraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review on July 22, 2026.
• Technical assessment has started, with initial questions focused on physicochemical characterization of the product intended for potential stockpiling.
• A regulatory decision could come as early as Q4 2026, which would be Entolimod’s first national registration if cleared.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608131000ACCESSWRNAPR_____1206949) on August 13, 2026, and is solely responsible for the information contained therein.